Maternus-Kliniken Aktiengesellschaft (MAK.DE) Stock Price

€1.31 0%

Sign up
to add to portfolio

AI Score

Hold
  • Alternative

    5
  • Fundamental

    2
  • Technical

    4

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Maternus-Kliniken Aktiengesellschaft, AI stock picks, stock alerts and much more.

Sign up

MAK.DE AI Stock Analysis

AI stock analysis for MAK.DE is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Maternus-Kliniken Aktiengesellschaft (MAK.DE) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Maternus-Kliniken Aktiengesellschaft (MAK.DE) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Maternus-Kliniken Aktiengesellschaft (MAK.DE), currently trading at €1.31, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About MAK.DE

LSE
  • Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate in the field of geriatric care and rehabilitation medicine.

  • Symbol

    MAK.DE

  • Market

    XETRA

  • Industry

    Medical - Care Facilities

  • Market Cap

    27.5M

Similar Stocks

News

No news articles.

MAK.DE Alternative Data

Web Traffic

Maternus-Kliniken Aktiengesellschaft receives an estimated 1826 monthly visitors to maternus.de.

  • Web Traffic

    1826

  • Change from Previous Month

    7.4%

  • 3 Month Change

    54.3%

  • YoY Change

    54.3%

Instagram Followers

Maternus-Kliniken Aktiengesellschaft has 527 Instagram Followers on its main Instagram account, up by 14.6% over the last month.

  • Instagram Followers

    527

  • Daily Change

    1.2%

  • 1 Month Change

    14.6%

  • 3 Month Change

    22.8%

Youtube Subscribers

Maternus-Kliniken Aktiengesellschaft has 782 subscribers on its main Youtube channel, up by 0.4% over the last month.

  • Youtube Subscribers

    782

  • Daily Change

    0%

  • 1 Month Change

    0.4%

  • 3 Month Change

    1.4%

News Mentions

Maternus-Kliniken Aktiengesellschaft was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

Maternus-Kliniken Aktiengesellschaft has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • 1 Month Change

    0%

  • 3 Month Change

    0%

MAK.DE Financials

MAK.DE Key Metrics
  • Total Revenue

    €57.1M

  • Net Income

    -€1.8M

  • Earnings per Share

    -€0.088

  • Free cash flow

    €6.3M

  • EBITDA

    €7.2M

  • EBITDA Ratio

    0.126444

  • Total Assets

    €150.6M

MAK.DE 2-year Revenue & Income
MAK.DE 2-year Free Cash Flow

MAK.DE Technicals

MAK.DE SMA
MAK.DE RSI

FAQ

What's the current price of Maternus-Kliniken Aktiengesellschaft (MAK.DE) Stock?
The price of an Maternus-Kliniken Aktiengesellschaft (MAK.DE) share is €1.31.

What's the market cap of Maternus-Kliniken Aktiengesellschaft?
The current market cap of Maternus-Kliniken Aktiengesellschaft is 27.5M.

Should I buy or sell MAK.DE?
Maternus-Kliniken Aktiengesellschaft shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Maternus-Kliniken Aktiengesellschaft is better viewed as a hold or accumulate position while waiting for further developments.

Is Maternus-Kliniken Aktiengesellschaft a good investment?
The current analysis of Maternus-Kliniken Aktiengesellschaft's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Maternus-Kliniken Aktiengesellschaft's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.

Is now a good time to buy Maternus-Kliniken Aktiengesellschaft (MAK.DE) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Maternus-Kliniken Aktiengesellschaft stock is currently neutral, suggesting a cautious approach might be wise.

What are some stocks similar to Maternus-Kliniken Aktiengesellschaft (MAK.DE) that investors often compare it to?
Maternus-Kliniken Aktiengesellschaft (MAK.DE) is often compared to similar stocks such as LIMES Schlosskliniken AG, VITA 34 AG, MEDICLIN Aktiengesellschaft, RHÖN-KLINIKUM Aktiengesellschaft and M1 Kliniken AG.

What is the forecast for Maternus-Kliniken Aktiengesellschaft's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Maternus-Kliniken Aktiengesellschaft's stock price to be around €1.27 in 2026. Starting from the current price of €1.31, this represents a 3.1% change in price, indicating a neutral outlook for the stock.

How to buy Maternus-Kliniken Aktiengesellschaft (MAK.DE) Stock?
Maternus-Kliniken Aktiengesellschaft stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Maternus-Kliniken Aktiengesellschaft shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.